Find out the latest news and activities of the Global Medicines Program at the University of Washington. Volume 1, Issue 2, Spring 2012.
UW Global Medicines Program
Strengthening Developing Nations' Regulatory Capacity for Food and Drug Safety:  Newly Released Report 
This month, a committee of the Institute of Medicine issued the report, Ensuring Safe Foods and Medical Products through Stronger Regulatory Systems Abroad.  Andy Stergachis served as a member of the committee.  It may surprise you to learn that more than 80 percent of active pharmaceutical ingredients and 40 percent of finished drugs come from abroad, as does 85 percent of the seafood consumed in the US. The US FDA largely depends on inspections but as the volume of imports grows, the FDA cannot do this well without substantial improvement in the capacity of its counterpart regulatory agencies in emerging economies.  Among the recommendations is a call to invest more in strengthening the capacity of regulatory systems and the need to provide more technical support for strengthening surveillance systems in developing countries. Read More

Expanded Access to Contraception Provides Economic Benefits to Sub-Saharan African Country
Two papers were recently published highlighting the work of Joseph Babigumira and colleagues on the economic analyses of unsafe abortions and on increasing access to contraception in Uganda.  His work used modeling methods to show that unsafe abortions cost the country substantial resources and that providing universal access to modern contraceptives would be highly cost-effective.  Projections show that that providing expanded access to contraception decreases the rates of total fertility, birth, maternal mortality, and child mortality while reducing costs of maternal health care.  The studies highlight the need to make expanded contraceptive coverage a public health priority.  He presented these findings the 6th African Population Conference in Ouagadougou, Burkina Faso on December 5-9, 2011.

Recent Publications 
Potential Cost-Effectiveness of Universal Access to Modern Contraceptives in Uganda. Babigumira JB, Stergachis A, Veenstra DL, Gardner JS, Ngonzi J, Mukasa-Kivunike P, Garrison LP. 2012 Feb 17. PLoS ONE 7(2). 
An assessment of the accuracy and availability of data in electronic patient tracking systems for patients receiving HIV treatment in central Mozambique. Lambdin BH, Micek MA, Koepsell TD, Hughes JP, Sherr K, Pfeiffer J, Karagianis M, Lara J, Gloyd SS, Stergachis A. BMC Health Serv Res. 2012 Feb.
Welcome to Our Newsletter!
From Our Director
The Global Medicines Program is a relatively new program of the University of Washington’s Department of Global Health.   My colleague and co-Director Professor Lou Garrison and I are pleased to keep you informed of our Program news and progress towards improving the use, safety, quality, benefit-risk profile, cost-effectiveness, and affordability of medicines. 

Andy Stergachis, PhD, Professor and Director, Global Medicines Program

Becky Bartlein and Global Medicines Faculty will be presenting at the 9th Annual Western Regional International Health Conference April 27-29, 2012 in Seattle, WA. Registration is open!

Applying Pharmacoeconomics to Essential Medicines Selection
Workshop led by Lou Garrison and Joseph Babigumira April 10-12, 2012, in Johannesburg, South Africa
Andy Stergachis and Joseph Babigumira will be presenting at  Africa Pharmacovigilance Meeting 2012 - Ensuring Quality and Safety of Medicines in Sub-Saharan Africa, to be held in Nairobi, Kenya April 18 - 20, 2012
Email Marketing Powered by Mailchimp